Biorestorative Therapies News

Biorestorative Therapies | SCHEDULE 13G/A: Others

Nov 14 12:37 ET

Biorestorative Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 13 22:34 ET

Biorestorative Therapies | 8-K: BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 13 16:14 ET

Biorestorative Therapies | 10-Q: Q3 2024 Earnings Report

Nov 12 16:22 ET

Biorestorative Therapies | 8-K: Current report

Nov 7 11:37 ET

Biorestorative Therapies | 8-K: Current report

Nov 6 16:47 ET

Biorestorative Therapies | 424B5: Prospectus

Nov 6 16:42 ET

Biorestorative Therapies | 10-K/A: Annual report (Amendment)

Nov 6 16:28 ET

Biorestorative Therapies | 4: Statement of changes in beneficial ownership of securities-10% Owner Broadrick Dale

Nov 5 16:38 ET

Biorestorative Therapies | 8-K: Current report

Sep 23 16:38 ET

Biorestorative Therapies | 10-Q: Q2 2024 Earnings Report

Aug 13 16:36 ET

Biorestorative Therapies | 8-K: Current report

Aug 13 16:15 ET

Biorestorative Therapies | DEF 14A: Definitive information statements

Aug 8 16:40 ET

Biorestorative Therapies | 8-K: Current report

Aug 6 16:49 ET

Biorestorative Therapies | SCHEDULE 13G: Others

Jun 21 18:36 ET

Biorestorative Therapies | 10-Q: Q1 2024 Earnings Report

Jun 11 16:34 ET

Biorestorative Therapies | 10-K/A: Annual report (Amendment)

Jun 11 16:28 ET

Biorestorative Therapies | 8-K: Current report

May 24 16:53 ET

Biorestorative Therapies | 8-K: Current report

May 24 16:50 ET

Biorestorative Therapies | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 16 17:22 ET